Peter J. Boerrigter
- Urology top 0.5%
- Rheumatology top 5%
- Epidemiology top 10%
- Reproductive Medicine top 10%
- Endocrinology, Diabetes and Metabolism
- Co-authors
- Christopher R. ChappleTed DrogendijkM. WooningJ. CambroneroJ.C. AnguloVik KhullarG. AmarencoPiotr Radziszewski
- Topics
- Urinary Bladder and Prostate Research (6 papers)Ovarian function and disorders (4 papers)Estrogen and related hormone effects (3 papers)
- Partner nations
- NetherlandsUnited KingdomSpain
In The Last Decade
Peter J. Boerrigter
12 papers receiving 635 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Urology 482
- Rheumatology 348
- Epidemiology 290
- Reproductive Medicine 96
- Endocrinology, Diabetes and Metabolism 92
Countries citing papers authored by Peter J. Boerrigter
This map shows the geographic impact of Peter J. Boerrigter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Boerrigter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Boerrigter more than expected).
Fields of papers citing papers by Peter J. Boerrigter
This network shows the impact of papers produced by Peter J. Boerrigter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Boerrigter. The network helps show where Peter J. Boerrigter may publish in the future.
Co-authorship network of co-authors of Peter J. Boerrigter
This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Boerrigter. A scholar is included among the top collaborators of Peter J. Boerrigter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Boerrigter. Peter J. Boerrigter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 107 | |
| 2 | The Potent and Selective Beta3-adrenoceptor Agonist Mirabegron Improves Patient-reported Outcomes in Overactive Bladder–Results from Two Phase III Studies | 1 |
| 3 | Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trialbreakdown → | 329 |
| 4 | The efficacy and tolerability of mirabegron, a potent and selective ß3-adrenoceptor agonist, compared with placebo and tolterodine slow release in patients with overactive bladder – results from a European–Australian Phase III trial | 4 |
| 5 | 34 | |
| 6 | 41 | |
| 7 | 20 | |
| 8 | 6 | |
| 9 | 40 | |
| 10 | 27 | |
| 11 | 17 | |
| 12 | 21 | |
| 13 | 14 |
About Peter J. Boerrigter
Peter J. Boerrigter is a scholar working on Urology, Reproductive Medicine and Endocrinology, Diabetes and Metabolism, having authored 13 papers that have together received 661 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (6 papers), Ovarian function and disorders (4 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Urology (482 citations), Rheumatology (348 citations) and Reproductive Medicine (96 citations). Peter J. Boerrigter has collaborated with scholars based in Netherlands, United Kingdom and Spain. Frequent co-authors include Christopher R. Chapple, Ted Drogendijk, M. Wooning, J. Cambronero, J.C. Angulo, Vik Khullar, G. Amarenco, Piotr Radziszewski, Tomasz Rechberger and Kjetil Høye. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Human Reproduction and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.